TTrialPathMatch Me to Trials
← Back to trials
RecruitingSleep Apnea Syndrome, Obstructive

Treatment Failure of Continuous Positive Airway Pressure (CPAP) in Patients With Obstructive Sleep Apnea Syndrome (OSA): A Trial Comparing Polysomnography and the Sunrise Device to Drive Treatment-Adjustment Decisions.

Eligible age

18–85 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this clinical trial is to determine whether treatment-adjustment decisions based on one night of home monitoring with the Sunrise device are comparable to decisions based on one night of in-laboratory polysomnography (PSG) in adults with obstructive sleep apnea (OSA) who remain insufficiently controlled with continuous positive airway pressure (CPAP) therapy. The main questions it aims to answer are: * Do Sunrise-based assessments lead to similar therapeutic decisions as PSG-based assessments? * Are residual apnea-hypopnea indices measured by Sunrise comparable to those measured by PSG? Participants will complete both assessment sequences in a randomized cross-over design. They will: * Use the Sunrise device for several nights with and without CPAP. * Undergo one night of PSG with and without CPAP. * Have their CPAP therapy reviewed based on the results of each assessment method.

Sponsor: University Hospital, Grenoble

You may qualify if…

  • Adults aged 18 to 85 years
  • Patients treated with Resmed CPAP
  • Residual apnea-hypopnea index under CPAP (rAHI(CPAP) \> 10 events/hour)
  • Access to a smartphone and home internet connection, and ability to use a mobile application
  • Signed informed consent
  • Affiliated with, or beneficiary of, a national health insurance program

You may not qualify if…

  • Severe chronic obstructive or restrictive pulmonary disease, with or without supplemental oxygen
  • Unstable cardiovascular disease or severe heart failure requiring hospitalization within the past 3 months, or meeting New York Heart Association (NYHA) class III or IV criteria
  • Conditions affecting mandibular condyle rotation or temporomandibular joint function
  • Refusal to shave excessive facial hair when required for proper placement of the Sunrise device
  • Participation in another interventional clinical study or currently within an exclusion period of another study
  • Individuals who, in the investigator's judgment, are unlikely to comply with study procedures or requirements
  • Individuals who cannot be contacted in case of emergency
  • Persons protected under French Public Health Code articles L1121-5, L1121-6, and L1121-8 (including pregnant or breastfeeding women, persons deprived of liberty, individuals under psychiatric care under articles L.3212-1 or L.3213-1, individuals admitted to healthcare or social institutions for reasons other than research, and persons under legal protection or unable to provide informed consent)

Source: ClinicalTrials.gov · NCT07530302 · last updated 2026-06-17